Category: Pharmacy

A Look At Cancer Immunotherapy And Some Key Players In 2017

Cancer immunotherapy, exploiting the abilities of the immune system to treat cancer, is fast becoming the standard of care for many malignancies and offers the best hope for curing patients of their disease. For biotech investors, the prospect of curing cancer has led to an abundance of opportunities as more and more companies enter the…

HedgePath Pharma Has Nice Upside As SUBA-Itraconazole Development Continues

Last month, I wrote an article introducing investors to HedgePath Pharmaceuticals, Inc. (HPPI), a Tampa-based biopharma company developing an improved, patent-protected, oral capsule formulation of itraconazole for the treatment of Basal Cell Carcinoma Nevus Syndrome (BCCNS) / Gorlin Syndrome. HedgePath is currently enrolling patients in a Phase 2b open-label trial (NCT02354261) of SUBA™-Itraconazole in subjects with…